🔓 Unlock the full profile of Steven Neier (Dana-Farber Cancer Institute), including verified contact details, financial insights, and professional associations.

See Steven Neier Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: ste*****@dan******.com

Mobile: 86148*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Steven Neier is a Co-Founder of multiple innovative organizations, including Dana-Farber Cancer Institute, NextRNA Therapeutics, and Microbial Machines, all based in Boston, Massachusetts.
  • At Dana-Farber Cancer Institute, Steven Neier has been instrumental in advancing cancer research and treatment since January 2021.
  • As a Co-Founder of NextRNA Therapeutics, Steven Neier contributes to the development of novel RNA-based therapeutics aimed at addressing unmet medical needs.
  • With a focus on biotechnology, Steven Neier has played a pivotal role in establishing Microbial Machines, a company dedicated to harnessing synthetic biology for breakthrough innovations.
  • Steven Neier previously served as a Scientific Program Manager at Dana-Farber Cancer Institute & Harvard Medical School, where important strategic projects in cancer research were managed from October 2019 until January 2021.
  • Before that, as a Scientific Consultant at QuantumCyte, Inc., Steven Neier provided expertise that enhanced the scientific rigor of projects from November 2018 to January 2021.
  • Steven Neier started the journey in cancer research with the role of Scientist I at Dana-Farber Cancer Institute & Harvard Medical School, contributing from October 2018 to September 2019.
  • During the early career phase, Steven Neier completed a Postdoctoral Research Fellowship at Dana-Farber Cancer Institute & Harvard Medical School, focusing on critical areas in cancer biology from September 2016 to July 2018.
  • Steven Neier holds a foundational background in biomedical sciences, including a Graduate Student role at Mayo Clinic Graduate School, starting in July 2011.